BWS Financial Upgrades Hawkins (NASDAQ:HWKN) to "Buy"

Hawkins (NASDAQ:HWKN - Get Free Report) was upgraded by BWS Financial from a "neutral" rating to a "buy" rating in a research note issued to investors on Monday, Marketbeat.com reports. The firm presently has a $160.00 target price on the specialty chemicals company's stock. BWS Financial's target price would indicate a potential upside of 31.55% from the stock's previous close. BWS Financial also issued estimates for Hawkins' Q4 2025 earnings at $0.73 EPS, FY2025 earnings at $3.99 EPS, Q1 2026 earnings at $1.32 EPS, Q2 2026 earnings at $1.25 EPS, Q3 2026 earnings at $0.95 EPS, Q4 2026 earnings at $1.09 EPS and FY2026 earnings at $4.62 EPS.

Separately, CJS Securities assumed coverage on Hawkins in a research report on Tuesday, April 1st. They set a "market outperform" rating and a $125.00 target price on the stock.

Hawkins Trading Up 0.3 %

Shares of NASDAQ:HWKN traded up $0.41 during midday trading on Monday, reaching $121.63. The company's stock had a trading volume of 88,138 shares, compared to its average volume of 123,869. Hawkins has a fifty-two week low of $71.98 and a fifty-two week high of $139.55. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.53 and a current ratio of 2.50. The firm has a 50 day moving average price of $108.45 and a two-hundred day moving average price of $117.73. The firm has a market capitalization of $2.55 billion, a price-to-earnings ratio of 31.03, a PEG ratio of 3.80 and a beta of 0.82.

Hawkins (NASDAQ:HWKN - Get Free Report) last issued its earnings results on Wednesday, January 29th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.77 by ($0.05). Hawkins had a return on equity of 18.95% and a net margin of 8.60%. As a group, analysts forecast that Hawkins will post 4 earnings per share for the current year.

Institutional Investors Weigh In On Hawkins

Several large investors have recently added to or reduced their stakes in HWKN. State Street Corp grew its position in shares of Hawkins by 5.4% in the third quarter. State Street Corp now owns 755,995 shares of the specialty chemicals company's stock valued at $96,367,000 after purchasing an additional 38,877 shares in the last quarter. Jane Street Group LLC lifted its position in Hawkins by 127.3% during the third quarter. Jane Street Group LLC now owns 47,432 shares of the specialty chemicals company's stock valued at $6,046,000 after purchasing an additional 26,568 shares during the last quarter. Barclays PLC grew its position in Hawkins by 180.1% in the third quarter. Barclays PLC now owns 39,728 shares of the specialty chemicals company's stock worth $5,064,000 after acquiring an additional 25,545 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Hawkins by 3.6% during the 3rd quarter. Geode Capital Management LLC now owns 523,514 shares of the specialty chemicals company's stock valued at $66,743,000 after purchasing an additional 18,119 shares during the last quarter. Finally, TD Private Client Wealth LLC raised its stake in shares of Hawkins by 242.5% during the third quarter. TD Private Client Wealth LLC now owns 459 shares of the specialty chemicals company's stock worth $59,000 after acquiring an additional 325 shares in the last quarter. Hedge funds and other institutional investors own 69.71% of the company's stock.

About Hawkins

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.